LY3848575

DRUG2 trials

Sponsors

Eli Lilly and Company

Conditions

Distal Sensory PolyneuropathyHealthyNeuropathic Pain

Phase 1

A Study of LY3848575 in Healthy Participants

CompletedNCT05727072

Eli Lilly and CompanyHealthy

Start: 2023-02-10End: 2024-02-19Updated: 2024-04-04

Phase 2

Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

CompletedNCT06568042

Eli Lilly and CompanyDistal Sensory Polyneuropathy, Neuropathic Pain

Start: 2024-08-22End: 2026-04-15Updated: 2026-07-10